COP vs LSTA · P/E 19, rev $58.94B vs rev $1.0M
ConocoPhillips (COP) versus Lisata Therapeutics Inc. (LSTA) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported LSTA revenue for 2024-12-31 was $1.0M. Net income was -$20.0M. LSTA currently screens at market cap $31.7M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. LSTA currently screens at market cap $31.7M.
Not investment advice. Open the COP and LSTA stock pages for the full models.
Not investment advice.